3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
2
Myelodysplastic Syndromes
1
Interventions
atezolizumab
3
Trastuzumab
2
tocilizumab
1
spartalizumab
1
pralsetinib
1
pertuzumab
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
olaparib
1
ipatasertib
1
inavolisib
1
fludarabine phosphate
1
fludarabine
1
entrectinib
1
cemiplimab
1
anlotinib
1
alectinib
1
adagrasib
1
Pemetrexed
1
Oxaliplatin
1
Nivolumab
1
Leucovorin
1
Irinotecan
1
Fluorouracil
1
Filgrastim
1
Docetaxel
1
Cyclophosphamide
1
Cetuximab
1
Capecitabine
1
Ado-Trastuzumab Emtansine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Solid Tumors
×
quizartinib
×
30 days
×
Clear all
No trials found.